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Transgenic mouseThe presynaptic protein α-synuclein is central to the pathogenesis of α-synucleinopathies. We show that the
presence of endogenous mouse α-synuclein leads to higher number of dopaminergic neurons in the substantia
nigra of wild-type C57Bl/6J mice compared with C57Bl/6S mice with a spontaneous deletion of the α-synuclein
gene or C57Bl/6Jmicewith a targeted deletion of theα-synuclein gene. This effect ofα-synuclein on dopaminergic
neuron occurs during development between E10.5 and E13.5 and persists in adult life supporting the involvement
of α-synuclein in the development of a subset of dopaminergic neurons.
© 2013 Elsevier Inc. Open access under CC BY-NC-ND license.Introduction
α-Synuclein is a presynaptic protein central to the pathogenesis of
Parkinson's disease (PD), the most common movement disorder (Lees
et al., 2009). Lewy bodies (LBs) containing ﬁbrillous α-synuclein and
dopaminergic cell death in the substantia nigra (SN) are deﬁning
neuropathological features of PD, and mutations or multiplications
of the α-synuclein gene (SNCA) are a cause of familial PD (Gasser,
2010; Polymeropoulos et al., 1997; Singleton et al., 2003; Spillantini
et al., 1997, 1998).
The physiological role of α-synuclein is still unclear although it is
known to bind to lipid membranes and to be implicated in SNARE-
mediated exocytosis and synaptic vesicle transport (Chandra et al.,
2005; Darios et al., 2010; Garcia-Reitbock et al., 2010; Burre et al.,
2010). We have previously reported a transgenic mouse in whichy Peninsula Schools ofMedicine
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NC-ND license.truncated (1-120) human α-synuclein is expressed in an endogenous
α-synuclein null background under the control of the tyrosine hydroxy-
lase (TH) promoter in dopaminergic cells (Tofaris et al., 2006).α-Syn(1-
120) transgenic mice develop amotor phenotype associated with ﬁbril-
lar/granular α-synuclein inclusions in the SN, coupled to a reduction in
striatal dopamine levels and impaired dopamine release associated
with SNARE protein redistribution in the absence of dopaminergic cell
death (Garcia-Reitbock et al., 2010; Tofaris et al., 2006).
We hypothesized that the presence of the endogenous mouse
α-synuclein protein might exacerbate the pathology in our model. To
test this we crossed the 1-120 α-syn mice with wild type (wt) C57Bl/
6J mice expressing the endogenous protein, generating the new α-
syn(1-120)E (E = endogenous) line (Garcia-Reitbock et al., 2010). Sur-
prisingly, the presence of endogenous mouse protein was associated
with a dose-dependent increase in the number of TH+ neurons in the
SN pars compacta of transgenic α-syn(1-120)E mice. In addition, the
absence of endogenous α-synuclein is also associated with a reduced
number of dopaminergic cells in the SN of wt CB57Bl/6S mouse sub-
line with a spontaneous deletion of the α-synuclein gene and in α-
synuclein knockout C57Bl/6J mice (Robertson et al., 2004) compared
to wt C57Bl/6J mice. This difference in dopaminergic neuron number
between wt C57Bl/6J mice and mice without endogenous α-synuclein
becomes apparent after embryonic day 10.5 (E10.5), indicating that
the endogenous mouse α-synuclein is involved in the development of
a subset of dopaminergic neurons in the SN.
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Generation of transgenic mice
The genotyping and characteristics ofα-syn (1-120) transgenicmice
have previously been described (Garcia-Reitbock et al., 2010; Tofaris
et al., 2006). α-Syn(1-120) mice are in C57Bl/6JOlahsd background
also known as C57Bl/6S (Harlan Laboratories) which lacks endogenous
mouseα-synuclein due to a spontaneous deletion in themouse genome
(Specht and Schoepfer, 2001). To obtain α-syn(1-120)E mice with
endogenous α-synuclein, α-syn(1-120) mice were crossed with wt
C57Bl/6J mice and the homozygosity of the endogenous protein was
determined by qPCR as well as western blotting and test breeding.
α-Synuclein knockout mice were previously described (Abeliovich et
al., 2000; Robertson et al., 2004). Littermate wild type C57Bl/6J mice
were used as control for the heterozygous and homozygous α-
synuclein KO mice.
Immunohistochemistry
For immunohistochemistry, mice at different ages were anesthetized
and perfused transcardially with 4% paraformaldehyde (PFA) in 0.1 M
phosphate buffer, pH 7.4, and processed as previously described
(Garcia-Reitbock et al., 2010; Tofaris et al., 2006). E10.5 and E13.5
C57Bl/6S and C57Bl/6J embryos were ﬁxed in 4% PFA by immersion for
6 h, followed by soaking in 30% sucrose in PBS. Twelvemicrometer coro-
nal sections were then serially sectioned on a cryostat and collected in 3
groups of 10 slides — the ﬁrst 10 slides covering the anterior part of the
embryo, then the middle and posterior part of the embryo. About 6 sec-
tions were present on each slide; the mesencephalic areas including
substantia nigra were present on 2–3 sections either in the end of anteri-
or group, or in the beginning of middle group. E10.5 and E13.5 α-
synuclein knockout embryos were cut into 14 μm sections using a cryo-
stat and sectionswere serially distributed onto 6 glass slides. Freeﬂoating
sections or slides were then processed for immunohistochemistry as de-
scribed before (Garcia-Reitbock et al., 2010; Tofaris et al., 2006). The pri-
mary antibodies used were: monoclonal mouse anti-α-synuclein (Syn1,
BD Transductions, 1:1000, recognizes both mouse and human α-
synuclein), monoclonal anti-tyrosine hydroxylase MAB318 (Chemicon,
1:2000), and polyclonal anti-tyrosine hydroxylase (Pel-Freeze, 1:1000).
Western blotting
Brainswere dissected and tissue lysed on ice in 10 volumes or 150 μl
of 50 mM Tris–HCl pH 7.4, 150 mM NaCl, 1% Triton X100, 0.5%
Deoxycholic acid (Calbiochem), 0.1% SDS and protease inhibitor cocktail
(Roche). Protein amountswere determined using the BCAProtein Assay
Kit (Pierce), 30 μg of protein were loaded on a 10–15% SDS-PAGE and
immunobloting performed as previously indicated (Garcia-Reitbock
et al., 2010; Tofaris et al., 2006) usingWestern LightningChemilumines-
cence Reagent Plus Kit (PerkinElmer, UK).
Measurement of dopamine and metabolites by HPLC were per-
formed as previously described (Garcia-Reitbock et al., 2010).
Stereological cell counting
Every 6th brain section (30micrometer thick, and 6 in totals) of per-
fused mouse brain tissue was processed for immunohistochemistry for
TH as described above. Cells were counted on an Olympus BX50micro-
scope using the Castgrid software from the samemanufacturer. To sep-
arate the SN from the ventral tegmental area, a vertical line was drawn
through the medial end of the cerebellar peduncle. All TH+ cells lateral
to the linewere counted. Between 5 and 6 animals/groupwere counted
for each experiment.
The number of cells in the SN pars compacta of adult brain was deter-
mined blind to the genotype of the mice and using the followingcalculations (West, 1999): N = Nv × Vref, in which Nv = Σ (Number of
cells counted) / (number ofwindows × areaofwindow × height ofwin-
dow) and Vref = Σ structure areas × 1 / Frequency × section thickness.
As it is difﬁcult to determine exactly the location of the prospective
SN pars compacta in E10.5 and E13.5 embryos, all TH+ cells inmesence-
phalic area of the neural tube were counted in 3–4 embryos of each line
of mice. TH+ neurons in embryos were quantiﬁed blind to genotype
using optical fractionator method and Stereo Investigator 9 Software
(MicroBright Field Bioscience Inc.), connected to Leica microscope
equipped with motorized stage and digital camera. Every 6th section
of the mouse brain was quantiﬁed, the area was selected under
low magniﬁcation, and quantiﬁcation was performed with oil-
immersion objective ×100. Counting frame was 40 × 40 μm, and
counting grid size was 168 × 187 μm. The total number of neurons
was calculated using software in-built equations. In total, 2–4 sections
were counted, depending on the age of embryos. In addition, the total
number of Cresyl violet-positive cell nuclei within the same area was
quantiﬁed to assess the total number of the cells per structure.
Results
Endogenous α-synuclein increases the number of dopaminergic neurons
To investigate whether the presence of endogenous mouse α-
synuclein could inﬂuence the toxicity of transgenic truncated 1-120
human α-synuclein we crossed α-syn (1-120) mice with wt C57Bl/6J
mice that express endogenous α-synuclein to generate α-syn(1-120)E
transgenic mice (Garcia-Reitbock et al., 2010). Western blot analysis
of olfactory bulb extracts conﬁrmed the expression of the endogenous
mouse protein and showed that the transgenic 1-120 α-synuclein was
about 30% of the endogenous mouse α-synuclein (Fig. 1A).
Surprisingly, TH staining showed an increase of TH+ cells in the SN of
18 month-old α-syn(1-120)E mice when compared to α-syn(1-120)
transgenic (Fig. 1B–D). Stereological counting of neurons conﬁrmed
that the presence of endogenous α-synuclein increased the number of
dopaminergic cells in the SN pars compacta of α-syn(1-120)E mice in
a dose-dependent manner, with 13% (4346 ± 163 cells, p = 0.03,
n = 6/group) and 20% (4601 ± 192 cells, p = 0.005, n = 5/group) in-
crease respectively in mice heterozygous and homozygous for the
endogenous mouse protein compared to α-synuclein deﬁcient mice
(3844 ± 143 cells, n = 5) (Fig. 1E). The effect of endogenous α-
synuclein on dopaminergic cell number in the SN was independent
of transgene expression, as a similar increase in TH+ neurons (5337 ±
252 cells, n = 6/group) was found in 6 month-old wt C57Bl/6J mice
with the endogenous protein compared to wt C57Bl/6S mice (4251 ±
262 cells, p = 0.01, n = 6/group) that do not express endogenous α-
synuclein due to a spontaneous deletion of the α-synuclein gene locus
(Fig. 1F). Furthermore, quantiﬁcation of TH+ cells in C57Bl/6J mice
where the α-synuclein gene was speciﬁcally knocked out (3629 ± 322
cells, p = 0.001, n = 6/group) supported our ﬁndings that α-
synuclein deﬁciency alone is sufﬁcient to affect the number of TH+ neu-
rons in the SN (Fig. 1F).
However, this increase in dopaminergic cell number did not affect
striatal dopamine levels in the α-syn(1-120)E mice (Fig. 1G) which
remained lower comparedwithwt C57Bl/6Smice as previously reported
in α-syn(1-120) mice (Garcia-Reitbock et al., 2010; Tofaris et al., 2006).
Endogenous α-synuclein affects dopaminergic cell number during
development
α-Synuclein is expressed at detectable levels at E12 (Hsu et al.,
1998), while TH+ cells appear in the mesencephalic areas between
E10 and E11 (Wallen et al., 1999). In order to determinewhen the effect
of α-synuclein on TH+ cells occurs during development, TH+ neurons
were counted in E13.5 and E10.5 embryos from α-synuclein KO
C57Bl/6J mice as well as wt C57Bl/6S and C57Bl/6J mice. No difference
Fig. 1. Western blot analysis of olfactory bulb (OB) extract demonstrates the expression of truncated human 1-120 α-synuclein in the presence of endogenous α-synuclein in α-syn
(1-120)E mice. Quantiﬁcation was performed by analyzing the relative optic density of the western blot bands from 3 animals (A); Staining with anti-TH antibody in the substantia
nigra of C57Bl/6S control (B), α-syn (1-120) mice (C), and homozygous α-syn(1-120)E mice (D) shows an increase in stereologically quantiﬁed TH+ cell numbers in Syn (1-120)E
mice (E), scale bar 100 μm, *p b 0.05, **p b 0.01; (F) Stereological quantiﬁcation of TH+ neurons in the substantia nigra of 6 month-old wt C57BL/6J, C57Bl/6S mice and C57Bl/6J α-
synuclein knockout mice. *p b 0.05, ns not signiﬁcant; (G) HPLC analysis does not show a signiﬁcant difference in striatal dopamine and dopamine metabolite levels between α-syn
(1-120)E and α-syn (1-120) mice with and without endogenous α-synuclein; TH+ cells in ventral mesencephalic areas (substantia nigra) of C57Bl/6J and C57Bl/6S wild type mice
embryos at E10.5 and E13.5 days of gestation (H), as well as α-synuclein heterozygous (+/−) and homozygous (−/−) knockout mouse embryos at E10.5 and E13.5 days of gestation
(I). Cell numbers were quantiﬁed stereologically and presented as percentage of control groups. The statistically signiﬁcant difference was observed between C57Bl/6J and C57Bl/6S
embryos at E13.5 (n = 3, p = 0.0143, two tailed t-test) and in the group of α-synuclein +/+, α-synuclein −/− and α-synuclein +/− (n = 4, 6 and 4 respectively, ** and *** by
one-way ANOVA).
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ﬁcient and normal wt strains at E10.5 (Figs. 1H, I). On the contrary, at
E13.5 we observed a clear difference in the number of TH+ neurons be-
tween the strains with and withoutα-synuclein, with C57Bl/6S embry-
os having 33% less TH+ cells compared to C57Bl/6J embryos (p =
0.0143, n = 3 per group) of the same age (Fig. 1H). Homozygous and
heterozygous α-synuclein knockout E13.5 embryos had 43% (4370 ±
477, n = 4) and 13% less TH+ cells (6659 ± 657, n = 6) respectively,
when compared to wt littermates (7605 ± 994, n = 4) used as control
(Fig. 1I). This change in TH+ neurons number is not due to the general
cell loss in homozygous α-synuclein knockout E13.5 embryos, as Nissl
staining did not reveal a statistically signiﬁcant difference between the
groups (data not shown). These data indicate that endogenous α-
synuclein exerts its effect during development, between E10.5 and E13.5.
Discussion
Although α-synuclein's function is not yet completely clear it is
known to be involved in plasticity (George et al., 1995), in regulationof neurotransmitter release and synaptic vesicle pool (Abeliovich
et al., 2000; Anwar et al., 2011; Garcia-Reitbock et al., 2010; Greten-
Harrison et al., 2010; Burre et al., 2010; Scott and Roy, 2012), and its
involvement in neurodevelopment (Simon et al., 2001) has also been
suggested.
We showhere that the presence of endogenousmouseα-synuclein is
associated with an increase in the number of TH+ cells in the SN of both
transgenic α-syn(1-120)E and wt C57Bl/6J mice compared to the trans-
genic line α-syn(1-120) and wt C57Bl/6S. This effect is dose-dependent
with homozygous mice for the endogenous protein exhibiting a signiﬁ-
cantly higher number of TH+ cells compared to heterozygous mice.
The same effect of α-synuclein and an increase in dopaminergic cell
numbers was seen in both young and old mice, indicating that during
development α-synuclein either prevents cell death or promotes differ-
entiation of dopaminergic neurons in the SN conditioning their number
during life.
We cannot exclude that the absence of endogenousα-synuclein can
inﬂuence behavior. C57BL/6S mice which lack the α-synuclein gene
have been reported to have reduced rotarod performance compared
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that levels of striatal dopamine are similar in the presence or absence of
α-synuclein in the α-syn(1-120) transgenic mice. We did not ﬁnd any
difference in young mice in the open ﬁeld test that was affected only
in 18 month-old α-syn(1-120) mice (Tofaris et al., 2006). Unfortu-
nately, due to the poor breeding of the α-syn(1-120)E mice it was
not possible to investigate whether they had a defect in dopamine
release in the striatum following K+ stimulation as we have done
in the α-syn(1-120) mice (Garcia-Reitbock et al., 2010).
Sinceα-syn(1-120) linewas produced onC57Bl/6Smice background,
where the endogenous α-synuclein genomic locus is spontaneously
deleted, an increase in the number of TH+ cells in the SN of transgenic
α-syn(1-120)E is due to theα-synuclein presence alone, as a similar de-
gree of TH+ cell differencewas observed betweenC57Bl/6S and C57Bl/6J.
We have demonstrated here that endogenous α-synuclein increases
the number of TH+ neurons in α-syn(1-120) mice excluding toxicity
in young mice, however the number of TH+ neurons in older α-
syn(1-120)E mice is lower than in younger C57Bl/6J mice and as
we have described full-length endogenousα-synuclein in the synap-
tic aggregates of α-syn(1-120)E mice (Garcia-Reitbock et al., 2010),
we cannot exclude its contribution to toxicity in older mice. More
studies are needed to clarify this point. The difference in the number
of TH+ neurons could also be due to the different age of the animals
(18 months vs 6 months), which is consistent with a previous study
that has demonstrated that the number of dopaminergic neurons in
the substantia nigra of mice declines with age (Tatton et al., 1991).
While this is the ﬁrst observation of the lower number of TH+ cell
in SN in a wild-type strain of mice, carrying spontaneous deletion of
α-synuclein genomic locus (C57Bl/6S vs C57Bl/6J), conﬂicting results
were observed in α-synuclein knock-out animals. Some groups did
not report changes in TH+ cell numbers in substantia nigra of
α-synuclein knockout mice (Abeliovich et al., 2000), others found
minor but signiﬁcant decrease in mice without α-synuclein (Robertson
et al., 2004; Al-Wandi et al., 2010; Thomas et al., 2011). Here we show
that α-synuclein knockout mice have less TH+ neurons in SN when
compared to endogenous α-synuclein containing strain C57Bl/6J,
strengthening the idea that α-synuclein deﬁcit alone is sufﬁcient to re-
sult in dopaminergic neuronal number difference. This effect of endoge-
nous α-synuclein occurred between E10.5 and E13.5 because while at
E10.5 we found no difference in TH+ neuron number between wt mice
with and without the endogenous protein and α-synuclein targeted
KO mice, a difference between strains with and without α-synuclein
was evident in E13.5 embryos (Michell et al., 2007; and present work).
α-Synuclein has been reported to be present at very low levels in some
areas in the rodent nervous system at E9.5 but in the SN it appears
only at E11.5, becomes consistent at E12.5 and increases later in develop-
ment reaching its highest level in adult brain (Hsu et al., 1998; Zhong
et al., 2010). In this studywe did not detect consistentα-synuclein stain-
ing in E10.5 mouse embryos. Our novel and unexpected result suggests
that α-synuclein expression is necessary for the appearance of a subset
of TH+ neurons in the SN duringmouse embryonic development, unfor-
tunately nomarkers are available to identify these neurons and to deter-
mine whether α-synuclein inﬂuences their differentiation or death.
Whetherα-synuclein stimulates proliferation of precursor cells, pre-
vents neuronal death or promotes differentiation of DA neurons re-
mains to be determined. Interestingly, however, it has been previously
reported thatα-synuclein mRNAwas not present in engrailed knockout
mice that show reduced survival of dopaminergic SN neurons (Simon
et al., 2001; 2003) suggesting an involvement ofα-synuclein in DA neu-
ron development. It is also not known whether a sudden lack of α-
synuclein or loss of its function in SN pars compacta could lead to the
death of someDAneurons in adulthood similar towhat has been report-
ed for Nurr1-dependent DA neurons (Kadkhodaei et al., 2009). If this
was the case it is possible that the loss of function ofα-synuclein besides
its aggregation could make the α-synuclein-dependent neurons more
prone to death in PD. This has to be kept in mind when designingtherapies aimed at reducing α-synuclein amount as treatment for PD.
On the other hand, a negative effect of α-synuclein overexpression
has also been reported in adult neurogenesis (Winner et al., 2004).
However, our study is focused on TH+ neurons of the SN and in mice
with and without the endogenous protein therefore examining the
physiological effect of α-synuclein rather than its overexpression. It
might be that the relationship between α-synuclein and dopaminergic
cell numbers is dose-dependent where at physiological concentrations
α-synuclein leads to their increase whereas at higher, toxic concentra-
tions it inhibits the proliferation of dopaminergic neuron precursors.
This would explain the observation that overexpression of α-
synuclein inhibits adult neurogenesis (Winner et al., 2004, 2012). The
data presented here will be particularly relevant for the interpretation
of results on effect/toxicity of treatments in mice with and without
the endogenous protein where the initial difference in neurons could
lead to misleading interpretation of α-synuclein role in toxicity.
In summary, we have identiﬁed an additional and novel role for
α-synuclein in the development of a subset of dopaminergic neurons
in the SN pars compacta, and demonstrate that this effect takes place
between E10.5 and E13.5. Further studies are needed to determine the
precise mechanism by which α-synuclein exerts this effect during de-
velopment and to clarify whether it is speciﬁc to dopaminergic neurons
or occurs also in other neuronal populations where α-synuclein is
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